Navigation Links
Gabapentin Shown Effective for Fibromyalgia Pain

BETHESDA, Md., June 11, 2007--New research supported by the National Institutes of Healths National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.

In the NIAMS-sponsored, randomized, double-blind clinical trial of 150 women (90 percent) and men with the condition, Lesley M. Arnold, M.D., director of the Womens Health Research Program at the University of Cincinnati College of Medicine, and her colleagues found that those taking gabapentin at dosages of 1,200 to 2,400 mg daily for 12 weeks displayed significantly less pain than those taking placebo. Patients taking gabapentin also reported significantly better sleep and less fatigue. For the majority of participants, the drug was well tolerated. The most common side effects included dizziness and sedation, which were mild to moderate in severity in most cases.

NIAMS Director Stephen I. Katz. M.D., Ph.D., remarked that While gabapentin does not have Food and Drug Administration approval for fibromyalgia, I believe this study offers additional insight to physicians considering the drug for their fibromyalgia patients. Fibromyalgia is a debilitating condition for which current treatments are only modestly effective, so a study such as this is potentially good news for people with this common, painful condition.

Fibromyalgia is a chronic disorder characterized by chronic, widespread muscle pain and tenderness, and is frequently accompanied by fatigue, insomnia, depression, and anxiety. It affects three million to six million Americans, mostly women, and can be disabling.


'"/>




Page: 1 2 3

Related medicine technology :

1. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
2. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
3. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
4. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
5. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
6. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
7. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
8. Cethromycin Shown Effective Against Anthrax in Study
9. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gabapentin Shown Effective for Fibromyalgia Pain
(Date:10/6/2008)...ard-winning video clips feature children, parents ... studies, BETHESDA, Md., Oct. 6 /PRNewswire-USNew...cines, research in children saves lives and improv...m the National Institutes of,Health (NIH), "Childr...linicalStudies.nhlbi.nih.gov ), offers parents and...
(Date:10/6/2008)...ata from SONIC Trial Showed REMICADE Therapy is Mo...ucosal Healing Compared with Standard ...la., Oct. 6 /- Data presented for the...th Crohn,s Disease Naive to,Immunomodulators and B...nto,the approach to care of patients with moderate...
(Date:10/6/2008)... - Conference Call Scheduled for 9:00 AM E... -- Dendreon Corporation (Nasdaq:,DNDN) announced ...alysis of,the Phase 3, randomized, double-blind, p...te AdenoCarcinoma Treatment, also known as D9902B)...efficacy of the,investigational active cellular im...
(Date:10/6/2008)...esign Concept of Other Product - Company,s Bioabso...posium, HONG KONG, Oct. 6 /- Data fr...ro-healing stent, OrbusNeich,s Genous Bio-engineer...nscatheter Cardiovascular,Therapeutics symposium, ... M.D., Ph.D., of the Academic Medical Center in,Am...
Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference 15186 1Mens Health Guide for Ages 40 60 Launched by NHS Choices 15182 1Researchers urge ethics guidelines for human genome research 15179 1Researchers urge ethics guidelines for human genome research 15179 2AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 1AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 2AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 3
(Date:10/6/2008)...t against childhood obesity, researcher notes , ...ee-quarters of middle schools have vending machine...study finds. , The research demonstrates that t...and "that those vending machines don,t always have...rus, a registered dietitian with the Center for Ob...
(Date:10/6/2008)...wire-FirstCall/ -- HealthSouth,Corporation (NYSE: ...ly,publicized investor meeting in New York City. P...30 a.m. EST at the Grand Hyatt New York, located a... follows:, 8:00 a.m. Continental Breakfast 8...ive Officer -- HealthSouth Overview a...
(Date:10/6/2008)...nel and their family members can take,anonymous on...STON, Oct. 6 /PRNewswire-USNewswire/ -- Military l...their families that are unique and,difficult. Some...atters get,worse and one problem can trigger other...check things out to see what is really happening.,...
(Date:10/6/2008)...University of California, San Diego School of Medi...ts bolsters production of a protective chemical no...n infections that are a common result of atopic de...study led by Richard Gallo, M.D., Ph.D., professo...logy at the UCSD School of Medicine and the Dermat...
Breaking Medicine News(10 mins):Health News:Vending Machines Found in Most Middle Schools 2Health News:HealthSouth to Hold Investor Meeting November 10, 2008 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:Oral vitamin D may help prevent some skin infections 2
...artmouth Medical School investigators are learning...levels found in drinking water in many areas of th...aper published online on Dec. 2 in the journal Che...ort that three different steroid hormones all show...
... new study finds that the anti-craving drug, Naltr... negative moods and women who are trying to quit s...st step towards individualized medicine, scientist...nicotine addiction and in treatment. Researchers...
...n experimental epilepsy drug, lacosamide, develope... reducing the frequency of seizures in patients// ...n Monday following the results of a phase 3 trial....were presented at the North American Regional Epil...
... Canadian Study finds that adolescence boys are at... the same age.// Researchers have found that the s...before adulthood. Cardiologists say that smoking, ...ome of the factors for the cause of high blood pre...
Other Medicine News:Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 2Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 3Health News:Teen Boys At Greater Risk To High Blood Pressure Than Girls 2
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: